Trial intelligence / Profile preview

Buccal infiltration of articaine vs mepivacaine for maxillary premolar extraction

TCTR20220715003Phase 4Unknown

Sponsor
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry , Chiangmai university
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of articaine, mepivacaine in pain, sponsored by Department of Oral and Maxillofacial Surgery, Faculty of Dentistry , Chiangmai university. Status: unknown.

02

Drugs

articainemepivacaine
03

Conditions

pain

Beyond the preview

Go deeper on TCTR20220715003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220715003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call